Helicos BioSciences Corporation
unknown
unknown
Stage
About
Helicos BioSciences Corporation was a publicly traded life sciences company that developed the Helicos Genetic Analysis Platform, an early DNA-sequencing instrument that imaged individual DNA molecules. The company sold its sequencing systems to research, drug discovery, and diagnostic organizations and ceased operations in 2012.
Explore Helicos BioSciences Corporation's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.